On July 21, according to Cansino Biotech, the company reached a cooperation agreement with its Pakistani partner AGP Limited on the 13-valent pneumococcal polysaccharide conjugate vaccine during the Pakistan-China inter-enterprise investment summit. The two sides will further explore the future development opportunities of this product in Pakistan.

Zhitongcaijing · 2d ago
On July 21, according to Cansino Biotech, the company reached a cooperation agreement with its Pakistani partner AGP Limited on the 13-valent pneumococcal polysaccharide conjugate vaccine during the Pakistan-China inter-enterprise investment summit. The two sides will further explore the future development opportunities of this product in Pakistan.